RECENT APPROACHES FOR SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
Last updated: 25 Dec 2024
10.21608/bfsa.2023.301257
Non-alcoholic fatty liver disease, Sodium glucose co-transporter 2 inhibitors, Insulin resistance, oxidative stress
Gehan
Heeba
H.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, El-Minia, Egypt
gehan_heeba@mu.edu.eg
Mohamed
Abolnaga
Y.
Department of Biochemistry, Faculty of Pharmacy, Minia University, El-Minia, Egypt
m_yehia96@hotmail.com
Eman
Othman
M.
Department of Biochemistry, Faculty of Pharmacy, Minia University, El-Minia, Egypt
eman.sholkamy@uni-wuerzburg.de
46
1
41495
2023-06-01
2023-01-09
2023-06-01
579
595
1110-0052
3009-7703
https://bpsa.journals.ekb.eg/article_301257.html
https://bpsa.journals.ekb.eg/service?article_code=301257
301,257
Original Article
1,096
Journal
Bulletin of Pharmaceutical Sciences Assiut University
https://bpsa.journals.ekb.eg/
RECENT APPROACHES FOR SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
Details
Type
Article
Created At
25 Dec 2024